Aqua Bio Technology ASA (OSL:ABTEC)
0.7100
-0.0790 (-10.01%)
At close: Aug 1, 2025
Aqua Bio Technology ASA Revenue
In the year 2024, Aqua Bio Technology ASA had annual revenue of 107.17M NOK with 472.00% growth. Aqua Bio Technology ASA had revenue of 46.12M in the half year ending December 31, 2024, with 595.36% growth.
Revenue
107.17M
Revenue Growth
+472.00%
P/S Ratio
0.72
Revenue / Employee
2.90M
Employees
37
Market Cap
77.28M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107.17M | 88.44M | 472.00% |
Dec 31, 2023 | 18.74M | 11.58M | 161.63% |
Dec 31, 2022 | 7.16M | 5.19M | 262.49% |
Dec 31, 2021 | 1.98M | 1.16M | 143.11% |
Dec 31, 2020 | 812.63K | -482.56K | -37.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 603.92M |
Nordhealth AS | 545.88M |
Photocure ASA | 522.86M |
Vistin Pharma ASA | 440.66M |
Omda AS | 442.14M |
ArcticZymes Technologies ASA | 102.97M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |